CLIA Certification for Alzheimer's Biomarkers at the Glenn Biggs Institute in San Antonio, TX

Abstract

Background: The Clinical Laboratory Improvement Amendments (CLIA) regulate laboratory testing to ensure accuracy, reliability, safety, and timeliness of results. Biomarkers are becoming crucial for early detection, diagnosis, monitoring, and personalized treatment of Alzheimer's disease (AD).